Given that Californian voters authorized state coffers to sell $3 billion in bonds to fund the California Institute for Regenerative Medicine (CIRM) with the expectation of health and financial benefits, what benchmarks should be used to measure the initiative's success?
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
<http://www.cirm.ca.gov/meetings/pdf/2006/12/120706_item_7.pdf> (Accessed February 2007).
National Academy of Sciences Committee on the Biological and Biomedical Applications of Stem Cell Research. Board on Life Sciences Natural Research Council, and Board on Neuroscience and Behavioral Health Institute of Medicine. Stem Cells and The Future of Regenerative Medicine (National Academy Press, Washington, DC, 2002). <http://books.nap.edu/books/0309076307/html/index.html> (Accessed February 2007).
Taymor, K.S., Scott, C.T. & Greely, H.T. Nat. Biotechnol. 24, 411–413 (2006).
California Institute for Regenerative Medicine, 17 Cal. Code of Regulations §§100300–100310 (as revised through November 2006).
<http://www.cirm.ca.gov/policies/pdf/ForProfitOrg.pdf> (Accessed February 2007).
The California Stem Cell Research and Cures Initiative. (2004) (Proposition 71). Cal Legis Serv Prop 71 (West). Enacted.
Weissman, I. J. Am. Med. Assoc. 294, 1359–1366 (2005).
LaPorte, R.E., Matsushima, M. & Chang, Y.F. in Diabetes in America. NIH Publication No. 95–1468 (eds. Harris, M.I. et al.) 37–46 (National Diabetes Data Group of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, 1995).
<http://www.cdc.gov/nchs/datawh/statab/unpubd/mortabs/gmwk310_10.htm> (Accessed February 2007).
<http://www.census.gov/popest/national/asrh/2005_nat_res.html> (Accessed February 2007).
Portuese, E. & Orchard, T. in Diabetes in America. NIH Publication No. 95–1468 (eds. Harris, M.I. et al.) 221–232 (National Diabetes Data Group of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, 1995).
Torrance, G.W. J. Health Econ. 5, 1–30 (1986).
Dolan, P. in Handbook of Health Economics, vol. 1, part 2 (eds. Culyer, A.J. & Newhouse, J.P.) 1723–1760 (Elsevier, Amsterdam, Holland, 2000).
Morgan, C.L. et al. Diabetic Med. 23, 1100–1105 (2006).
Bagust, A., Wilson, E., Downs, K.E., Perry, A.S. & Harrison, D.J. Diabetes 51 Supplement 2, A270 (2002).
UKPDS Group. Diabetes Care 22, 1125–1136 (1999).
Huang, E.S., Shook, M., Jin, L., Chin, M.H. & Meltzer, D.O. Diabetes Care 29, 259–264 (2006).
Hirth, R.A., Chernew, M.E., Miller, E., Fendrick, A.M. & Weissert, W.C. Med. Decis. Making 20, 332–342 (2000).
<http://www.bls.gov/ncs/ocs/sp/ncbl0635.pdf> (Accessed February 2007).
Javitt, J.C. & Chiang, Y.-P. in Diabetes in America. NIH Publication No. 95–1468 (eds. Harris, M.I. et al.) 601–612 (National Diabetes Data Group of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, 1995).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
L.C.B. was a consultant to Proposition 71 during the campaign. M.T.L. is the recipient of a training grant from CIRM and H.T.G. is a faculty member on the training grant. Stanford University, the employer for M.T.L., L.C.B. and H.T.G., has been the recipient of training grants, SEED grants and comprehensive grants from CIRM.
Supplementary information
Rights and permissions
About this article
Cite this article
Longaker, M., Baker, L. & Greely, H. Proposition 71 and CIRM—assessing the return on investment. Nat Biotechnol 25, 513–521 (2007). https://doi.org/10.1038/nbt0507-513
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0507-513
This article is cited by
-
Sub-national technology policy and commerce: evaluating the impacts of the California Institute for Regenerative Medicine
The Journal of Technology Transfer (2018)
-
International stem cell environments: a world of difference
Nature Reports Stem Cells (2009)
-
The Stem Cell Research Environment: A Patchwork of Patchworks
Stem Cell Reviews and Reports (2009)
-
California stem-cell research: assessing return on investment
Nature Reports Stem Cells (2007)